휴메딕스

휴메딕스 appears in our data through filings on 엔솔바이오사이언스 shares, published by DART (FSS). We count 2 filings; the first trade dates from 21 February 2023 and the latest from 2 January 2025.

The open-market side counts 1 purchase alongside 1 sale. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at no purchases and 1 sale.

On 8 January 2025 came the latest disclosure, an open-market sale in 엔솔바이오사이언스. The clock since the last published purchase (21 February 2023) now reads 1,358 days. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.